Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 5, 2006, Pages 935-938

  Hebbring, Scott J ^a   Fredriksson, Henna ^b   White, Kirsten A ^d   Maier, Christiane ^e   Ewing, Charles ^f   McDonnell, Shannon K ^a   Jacobsen, Steven J ^a   Cerhan, James ^a   Schaid, Daniel J ^a   Ikonen, Tarja ^b   Autio, Ville ^c   Tammela, Teuvo L J ^c   Herkommer, Kathleen ^e   Paiss, Thomas ^e   Vogel, Walther ^e   Gielzak, Marta ^f   Sauvageot, Jurga ^f   Schleutker, Johanna ^b   Cooney, Kathleen A ^d   Isaacs, William ^f   Thibodeau, Stephen N ^a,g   more..

^a Mayo Clinic   (United States)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NIBRIN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FAMILIAL DISEASE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; NIJMEGEN BREAKAGE SYNDROME; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 33744718463     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0910     Document Type: Article

References (32)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 2004;13:R103-21.
3. Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB. The role of inflammation in the pathogenesis of prostate cancer [discussion S11-2]. J Urol 2004;172:S6-11.
4. Easton DF, Schaid DJ, Whittemore AS, Isaacs WJ. Where are the prostate cancer genes? A summary of eight genome wide searches. Prostate 2003;57:261-9.
5. Cybulski C, Gorski B, Debniak T, et al. NBS1 is a prostate cancer susceptibility gene. Cancer Res 2004;64:1215-9.
6. Carney JP, Maser RS, Olivares H, et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 1998;93:477-86.
7. Steffen J, Varon R, Mosor M, et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer 2004;111:67-71.
8. Buslov KG, Iyevleva AG, Chekmariova EV, et al. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int J Cancer 2005;114:585-9.
9. Debniak T, Gorski B, Cybulski C, et al. Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin. Melanoma Res 2003;13:365-70.
10. Gorski B, Debniak T, Masojc B, et al. Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer 2003;106:379-81.
11. Resnick IB, Kondratenko I, Pashanov E, et al. 657del5 mutation in the gene for Nijmegen breakage syndrome in a cohort of Russian children with lymphoid tissue malignancies and controls. Am J Med Genet A 2003;120:174-9.
12. Soucek P, Gut I, Trneny M, et al. Multiplex single-tube screening for mutations in the Nijmegen breakage syndrome gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin. Eur J Hum Genet 2003;11:416-9.
13. Plisiecka-Halasa J, Dansonka-Mieszkowska A, Rembiszewska A, Bidzinski M, Steffen J, Kupryjanczyk J. Nijmegen breakage syndrome gene alterations and its protein (nibrin) expression in human ovarian tumours. Ann Hum Genet 2002;66:353-9.
14. Wang L, McDonnell SK, Elkins DA, et al. Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 2002;71:116-23.
15. Schleutker J, Matikainen M, Smith J, et al. A genetic epidemiological study of hereditary prostate cancer in Finland: frequent HPCX linkage in families with late-onset disease. Clin Cancer Res 2000;6:4810-5.
16. Syrjakoski K, Fredriksson H, Ikonen T, et al. Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients. Int J Cancer 2006;118:518-20.
17. Lange EM, Gillanders EM, Davis CC, et al. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 2003;57:326-34.
18. Maier C, Haeusler J, Herkommer K, et al. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br J Cancer 2005;92:1159-64.
19. Schaid DJ, Chang BL. Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. Prostate 2005;63:276-90.
20. Syvanen AC. Solid-phase minisequencing as a tool to detect DNA polymorphism. Methods Mol Biol 1998;98:291-8.
21. Gorski B, Cybulski C, Huzarski T, et al. Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 2005;92:19-24.
22. Stumm M, von Ruskowsky A, Siebert R, et al. No evidence for deletions of the NBS1 gene in lymphomas. Cancer Genet Cytogenet 2001;126:60-2.
23. Stanulla M, Stumm M, Dieckvoss BO, et al. No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence. Br J Haematol 2000;109:117-20.
24. Rischewski J, Bismarck P, Kabisch H, Janka-Schaub G, Obser T, Schneppenheim R. The common deletion 657del5 in the Nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population. Leukemia 2000;14:1528-9.
25. Varon R, Seemanova E, Chrzanowska K, et al. Clinical ascertainment of Nijmegen breakage syndrome and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet 2000;8:900-2.
26. Medina PP, Ahrendt SA, Pollan M, Fernandez P, Sidransky D, Sanchez-Cespedes M. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations. Cancer Epidemiol Biomarkers Prev 2003;12:699-704.
27. Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002;11:1399-407.
28. Forsti A, Angelini S, Festa F, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep 2004;11:917-22.
29. Zhang L, Zhang Z, Yan W. Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 2005;359:150-5.
30. Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004;25:729-34.
31. Cerosaletti KM, Morrison VA, Sabath DE, Willerford DM, Concannon P. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma. Genes Chromosomes Cancer 2002;35:282-6.
32. Seemanova E, Sperling K, Neitzel H, et al. Nijmegen breakage syndrome with neurological abnormalities and without chromosomal instability. J Med Genet 2005.